Next Article in Journal
Pedestrians’ Perceptions of Motorized Traffic Variables in Relation to Appraisals of Urban Route Environments
Next Article in Special Issue
Impact of Manufacturing Agglomeration on the Green Innovation Efficiency—Spatial Effect Based on China’s Provincial Panel Data
Previous Article in Journal
Design and Implementation of a Chain-Type Direct Push Drilling Rig for Contaminated Sites
Previous Article in Special Issue
Inheritance and Innovation of Pottery Sculpture Technique in Shiwan, China: A Grounded Study from Cultural Ecology
 
 
Article
Peer-Review Record

Assessment of Patient Treatment and Rehabilitation Processes Using Electromyography Signals and Selected Industry 4.0 Solutions

Int. J. Environ. Res. Public Health 2023, 20(4), 3754; https://doi.org/10.3390/ijerph20043754
by Ewa Stawiarska 1,* and Maciej Stawiarski 2
Reviewer 1:
Reviewer 2:
Int. J. Environ. Res. Public Health 2023, 20(4), 3754; https://doi.org/10.3390/ijerph20043754
Submission received: 23 January 2023 / Revised: 17 February 2023 / Accepted: 18 February 2023 / Published: 20 February 2023

Round 1

Reviewer 1 Report

Dear. Authors,

Overall, this research paper is very fresh and exciting as it deals with the convergence of the healthcare business and Industry 4.0 solutions. Since this research paper deals with an unfamiliar topic, I got the impression that the explanation of related concepts was a bit excessive, but it was not a big problem.

There is a spelling error (SR1) in the descriptions of rows DR2 and DR5 in Table 1. Please check and correct.

 

Thank you.

 

Author Response

Reply to reviewer

First of all, thank you very much for your positive review and good opinion.

 We corrected the indicated description in the table and made a slight linguistic correction (linguistic corrections were made by a native English speaker).

Based on the feedback from both reviewers, we also made the following changes:

- references to the text in the introduction have been supplemented (they are now quotes 6,7,8,9),

- due to the introduction of references 6-9, the order of the following articles cited has also changed,

- missing markings in tables and figures have been corrected,

- it was justified why the DL1 process stage is similarly assessed by the respondents. The justification in the text reads as follows:

 

 “The respondents gave similar ratings for the DL1 (exploratory diagnosis and identi-fication of specialists for consultation) stage. All assessment criteria, i.e. cost, value for mental health, time and identified risks, received the same rating. This is because the respondents were injured (meaning that they were not subjected to EMG signals at the DL1 stage and did not use Industry 4.0 solutions to prepare for treatment). Similar studies conducted among doctors would probably show differences in the assessment of the DL1 stage for the criteria of cost, value for the patient’s mental health, time, and identified risks. It is planned to conduct similar studies among doctors and physiotherapists in the future.

 

Thank you very much once again.

Authors

Author Response File: Author Response.docx

Reviewer 2 Report

This work investigates that the use of EMG signals and selected Industry 4.0 solutions will improve the effectiveness and efficiency of treatment and rehabilitation processes for patients with musculoskeletal injuries. The manuscript is well written and data presented is reasonable, so I think it can be published after minor revisions as below:

1.     The last three paragraphs of Introduction lack references. Please add some related references. For instance, in lines 52-55, the references related to monitoring the patient's body can be added, such as “Fang C, et al. EMG-centered multisensory based technologies for pattern recognition in rehabilitation: state of the art and challenges[J]. Biosensors, 2020, 10(8): 85.”, “Hong Y, et al. Highly anisotropic and flexible piezoceramic kirigami for preventing joint disorders[J]. Science Advances, 2021, 7(11): eabf0795.” And “Kim J, et al. Wearable biosensors for healthcare monitoring[J]. Nature biotechnology, 2019, 37(4): 389-406.”

2.     Please check the “DL1a” in Figure 1 and Figure 4. And the “DL1” is missing in Figure 1 and the “DL1” and “DL2” are missing in Figure 4.

3.   It’s better for the authors to explain that why there is nearly no change for the DL1 group in the three process evaluations.

Author Response

Reply to reviewer

First of all, thank you very much for your positive review and good opinion.

 We corrected the indicated description in the table and made a slight linguistic correction (linguistic corrections were made by a native English speaker).

Based on the feedback from both reviewers, we also made the following changes:

- references to the text in the introduction have been supplemented (they are now quotes 6,7,8,9),

- due to the introduction of references 6-9, the order of the following articles cited has also changed,

- missing markings in tables and figures have been corrected,

- it was justified why the DL1 process stage is similarly assessed by the respondents. The justification in the text reads as follows:

 

 “The respondents gave similar ratings for the DL1 (exploratory diagnosis and identi-fication of specialists for consultation) stage. All assessment criteria, i.e. cost, value for mental health, time and identified risks, received the same rating. This is because the respondents were injured (meaning that they were not subjected to EMG signals at the DL1 stage and did not use Industry 4.0 solutions to prepare for treatment). Similar studies conducted among doctors would probably show differences in the assessment of the DL1 stage for the criteria of cost, value for the patient’s mental health, time, and identified risks. It is planned to conduct similar studies among doctors and physiotherapists in the future.

 

Thank you very much once again.

Authors

Author Response File: Author Response.docx

Back to TopTop